AGILON HEALTH INC (AGL) Stock Analyst Earnings Estimates
NYSE:AGL - New York Stock Exchange, Inc. - US00857U1079 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.708B 47.70% | 4.316B 59.38% | 6.061B 40.41% | 6.189B 2.12% | 7.055B 13.99% | 8.275B 17.29% | 10.848B 31.09% | 11.475B 5.78% | 10.246B -10.71% | 11.384B 11.11% | |
| EBITDA YoY % growth | -106.63M 71.89% | -211.972M -98.79% | -264.071M -24.58% | -76.582M 71.00% | -12.52M 83.65% | 109.28M 972.85% | 180.43M 65.11% | 161.7M -10.38% | 193.92M 19.93% | 232.2M 19.74% | |
| EBIT YoY % growth | -120.4M 69.44% | -232.133M -92.80% | -288.534M -24.30% | -213.394M 26.04% | -119.895M 43.82% | -87.466M 27.05% | 14.951M 117.09% | -16.665M -211.46% | 4.141M 124.85% | 29.593M 614.63% | |
| Operating Margin | -4.45% | -5.38% | -4.76% | -3.45% | -1.70% | -1.06% | 0.14% | -0.15% | 0.04% | 0.26% | |
| EPS YoY % growth | -0.26 75.70% | -0.49 -88.46% | -0.63 -28.57% | -0.40 35.94% | -0.26 36.45% | 0.10 139.38% | 0.37 270.00% | N/A | N/A | N/A |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 -26.25% | -0.07 6.52% | -0.13 53.90% | -0.16 37.82% | -0.01 -7.20% | -0.05 27.77% | -0.07 47.87% | -0.10 37.28% |
| Revenue Q2Q % growth | 1.57B -2.14% | 1.518B 2.38% | 1.495B 3.04% | 1.523B 0.03% | 1.726B 9.94% | 1.721B 13.37% | 1.718B 14.92% | 1.762B 15.69% |
| EBITDA Q2Q % growth | 14.635M 1,197.08% | -5.057M 83.99% | -36.382M 68.51% | -52.17M 34.82% | 27.719M 89.40% | 10.148M 300.69% | -14.339M 60.59% | -38.62M 25.97% |
| EBIT Q2Q % growth | 5.045M 170.28% | -28.022M 35.35% | -69.946M 47.61% | -76.761M 26.55% | -1.212M -124.02% | -4.141M 85.22% | -49.187M 29.68% | -40.299M 47.50% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.26 36.59% | -0.23 | -0.03 | -12.63% |
| Q3 2024 Q2Q % growth | -0.29 -262.50% | -0.11 | -0.18 | -171.08% |
| Q2 2024 Q2Q % growth | -0.07 -75.00% | -0.08 | 0.01 | 14.11% |
| Q1 2024 Q2Q % growth | -0.01 -125.00% | -0.01 | 0.00 | 18.64% |
| Q4 2023 Q2Q % growth | -0.41 -192.86% | -0.30 | -0.11 | -34.90% |
| Q3 2023 Q2Q % growth | -0.08 -14.29% | -0.06 | -0.02 | -39.16% |
| Q2 2023 Q2Q % growth | -0.04 20.00% | -0.03 | -0.01 | -55.98% |
| Q1 2023 Q2Q % growth | 0.04 | 0.02 | 0.02 | 81.50% |
| Q4 2022 Q2Q % growth | -0.14 | -0.09 | -0.05 | -61.18% |
| Q3 2022 Q2Q % growth | -0.07 22.22% | -0.05 | -0.02 | -38.61% |
| Q2 2022 Q2Q % growth | -0.05 93.67% | -0.02 | -0.03 | -175.03% |
| Q1 2022 Q2Q % growth | 0.00 100.00% | 0.00 | 0.00 | -100.00% |
| Q4 2021 Q2Q % growth | -0.14 | -0.11 | -0.03 | -26.01% |
| Q3 2021 Q2Q % growth | -0.09 | -0.10 | 0.01 | 7.82% |
| Q2 2021 Q2Q % growth | -0.79 | -0.06 | -0.73 | -1,322.14% |
| Q1 2021 Q2Q % growth | -0.05 | -0.03 | -0.02 | -65.02% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 1.522B 44.16% | 1.531B | -8.514M | -0.56% |
| Q3 2024 Q2Q % growth | 1.451B 19.35% | 1.485B | -34.068M | -2.29% |
| Q2 2024 Q2Q % growth | 1.483B 29.04% | 1.575B | -92.242M | -5.86% |
| Q1 2024 Q2Q % growth | 1.604B 41.21% | 1.62B | -15.646M | -0.97% |
| Q4 2023 Q2Q % growth | 1.056B 53.10% | 1.028B | 28.073M | 2.73% |
| Q3 2023 Q2Q % growth | 1.216B 74.94% | 1.149B | 66.66M | 5.80% |
| Q2 2023 Q2Q % growth | 1.149B 71.47% | 1.122B | 27.052M | 2.41% |
| Q1 2023 Q2Q % growth | 1.136B 73.88% | 1.089B | 47.147M | 4.33% |
| Q4 2022 Q2Q % growth | 689.8M 49.02% | 671M | 18.8M | 2.80% |
| Q3 2022 Q2Q % growth | 694.9M 51.53% | 660.61M | 34.29M | 5.19% |
| Q2 2022 Q2Q % growth | 670.1M 34.29% | 654.46M | 15.64M | 2.39% |
| Q1 2022 Q2Q % growth | 653.4M 58.17% | 648.65M | 4.75M | 0.73% |
| Q4 2021 Q2Q % growth | 462.9M | 457.42M | 5.48M | 1.20% |
| Q3 2021 Q2Q % growth | 458.6M 46.66% | 454.85M | 3.75M | 0.82% |
| Q2 2021 Q2Q % growth | 499M 69.96% | 478.03M | 20.97M | 4.39% |
| Q1 2021 Q2Q % growth | 413.1M 41.96% | 409.55M | 3.55M | 0.87% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 14.5% | 62.88% | 0% | -3.53% |
| Revenue | -8.35% | -10.34% | -7.02% | -10.58% |